SGC 0946

Catalog No.S7079 Batch:S707901

Print

Technical Data

Formula

C28H40BrN7O4
Molecular Weight 618.57 CAS No. 1561178-17-3
Solubility (25°C)* In vitro DMSO 100 mg/mL (161.66 mM)
Ethanol 100 mg/mL (161.66 mM)
Water Insoluble
In vivo (Add solvents to the product individually and in order)
Clear solution
5%DMSO 40%PEG300 5%Tween80 50%ddH2O
5.0mg/ml Taking the 1 mL working solution as an example, add 50 μL of 100 mg/ml clarified DMSO stock solution to 400 μL of PEG300, mix evenly to clarify it; add 50 μL of Tween80 to the above system, mix evenly to clarify; then continue to add 500 μL of ddH2O to adjust the volume to 1 mL. The mixed solution should be used immediately for optimal results. 
Clear solution
5% DMSO 95% Corn oil
0.5mg/ml Taking the 1 mL working solution as an example, add 50 μL of 10 mg/ml clear DMSO stock solution to 950 μL of corn oil and mix evenly. The mixed solution should be used immediately for optimal results. 
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
* Room temperature shipping (Stability testing shows this product can be shipped without any cooling measures.)

Preparing Stock Solutions

Biological Activity

Description SGC 0946 is a highly potent and selective DOT1L methyltransferase inhibitor with IC50 of 0.3 nM in a cell-free assay, is inactive against a panel of 12 PMTs and DNMT1.
Targets
DOT1L [1]
(Cell-free assay)
0.3 nM
In vitro

SGC 0946 is over 100-fold selective for other histone methyltransferases/HMTs. SGC 0946 potently reduces H3K79 dimethylation with IC50 of 2.6 nM in A431 cells, and 8.8 nM in MCF10A cells, which potently and selectively kills cells containing an MLL translocation. SGC 0946 is much more potent than its close analog EPZ004777, and serves as an excellent chemical probe for investigating DOT1L and further development of DOT1L inhibitors for cancer therapy. [1]
In vivo

SGC0946, a highly potent and selective DOT1L methyltransferase inhibitor, resulted in significant inhibition of tumor progression in the ovarian orthotopic xenograft mice model.
Features Cell-active DOT1L-selective chemical probe.

Protocol (from reference)

Cell Assay:

[1]
  • Cell lines

    Molm13 cell

  • Concentrations

    1 µM

  • Incubation Time

    4 days

  • Method

    Cells were treated with indicated concentration of drug for 4 days.

Selleck's SGC 0946 has been cited by 22 publications

Micronucleus is not a potent inducer of the cGAS/STING pathway [ Life Sci Alliance, 2024, 7(4)e202302424] PubMed: 38307626
Generation and characterization of giant panda induced pluripotent stem cells [ Sci Adv, 2024, 10(38):eadn7724] PubMed: 39303041
DOT1L stimulates MYC/Mondo transcription factor activity by promoting its degradation cycle on chromatin [ bioRxiv, 2024, 2024.02.06.579191] PubMed: 38370658
Histone H3K79 methylation by DOT1L promotes Aurora B localization at centromeres in mitosis [ Cell Rep, 2023, 42(8):112885] PubMed: 37494186
Transcriptome-based chemical screens identify CDK8 as a common barrier in multiple cell reprogramming systems [ Cell Rep, 2023, 42(6):112566] PubMed: 37235474
The human leukemic oncogene MLL-AF4 promotes hyperplastic growth of hematopoietic tissues in Drosophila larvae [ iScience, 2023, 26(10):107726] PubMed: 37720104
The human leukemic oncogene MLL-AF4 promotes hyperplastic growth of hematopoietic tissues in Drosophila larvae [ iScience, 2023, 26(10):107726] PubMed: 37720104
Derivation of totipotent-like stem cells with blastocyst-like structure forming potential [ Cell Res, 2022, 10.1038/s41422-022-00668-0] PubMed: 35508506
Histone methyltransferase Dot1L recruits O-GlcNAc transferase to target chromatin sites to regulate histone O-GlcNAcylation [ J Biol Chem, 2022, 298(7):102115] PubMed: 35690146
DOT1L inhibition does not modify the sensitivity of cutaneous T cell lymphoma to pan-HDAC inhibitors in vitro [ Front Genet, 2022, 13:1032958] PubMed: 36425063

RETURN POLICY
Selleck Chemical’s Unconditional Return Policy ensures a smooth online shopping experience for our customers. If you are in any way unsatisfied with your purchase, you may return any item(s) within 7 days of receiving it. In the event of product quality issues, either protocol related or product related problems, you may return any item(s) within 365 days from the original purchase date. Please follow the instructions below when returning products.

SHIPPING AND STORAGE
Selleck products are transported at room temperature. If you receive the product at room temperature, please rest assured, the Selleck Quality Inspection Department has conducted experiments to verify that the normal temperature placement of one month will not affect the biological activity of powder products. After collecting, please store the product according to the requirements described in the datasheet. Most Selleck products are stable under the recommended conditions.

NOT FOR HUMAN, VETERINARY DIAGNOSTIC OR THERAPEUTIC USE.